SCHEMBL6625880

SCHEMBL6625880

CC(C)(C)OC(=O)N1C2CCCC1C(=O)N(CCc1ccccc1)CC2

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FKBP1A P62942 3/20 0.44
KMT2A Q03164 2/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
STS P08842 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC8 Q9BY41 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
FKBP5 Q13451 1/20 0.41
JAK2 O60674 1/20 0.40
JAK1 P23458 1/20 0.40
PLA2G10 O15496 1/20 0.40
PLA2G5 P39877 1/20 0.40
CYP2D6 P10635 2/20 0.39
SMAD3 P84022 1/20 0.39
MEN1 O00255 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39
TSHR P16473 1/20 0.39
CYP2C19 P33261 1/20 0.39
RAB9A P51151 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6775961 0.84 KMT2A (0.42) FKBP1AKMT2AL3MBTL1STSFKBP5
SCHEMBL6785002 0.84 KMT2A (0.41) FKBP1AKMT2AL3MBTL1STSFKBP5
SCHEMBL6778841 0.83 KMT2A (0.41) FKBP1AKMT2AL3MBTL1STSFKBP5
SCHEMBL6780351 0.79 KMT2A (0.40) FKBP1AKMT2AL3MBTL1STSJAK2
SCHEMBL15436127 0.78 FKBP5 (0.50) FKBP1AKMT2AFKBP5MEN1TSHR
SCHEMBL6628799 0.77 FKBP5 (0.69) FKBP1AFKBP5ALDH1A1
SCHEMBL6776517 0.73 FKBP5 (0.45) FKBP1AKMT2AL3MBTL1FKBP5TSHR
SCHEMBL9977203 0.72 SRC (0.49) KMT2AL3MBTL1HDAC1HDAC8HDAC6
Benzylamine SCHEMBL18049727 0.72 KMT2A (0.47) KMT2AL3MBTL1STSHDAC1JAK2
SCHEMBL2301209 0.71 KMT2A (0.55) KMT2AL3MBTL1STSJAK2JAK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1098897-B1 COMPOUNDS, COMPOSITIONS, AND METHODS FOR STIMULATING NEURONAL GROWTH AND ELONGATION AGOURON PHARMA (US) 2004-06-09 EP disclosed
US-6630472-B1 Peptidyl-prolyl isomerase inhibitors PFIZER INC 2003-10-07 US disclosed
EP-1098897-A1 COMPOUNDS, COMPOSITIONS, AND METHODS FOR STIMULATING NEURONAL GROWTH AND ELONGATION AGOURON PHARMACEUTICALS, INC. (US) 2001-05-16 EP disclosed
WO-2000004020-A1 COMPOUNDS, COMPOSITIONS, AND METHODS FOR STIMULATING NEURONAL GROWTH AND ELONGATION AGOURON PHARMACEUTICALS, INC. (US) 2000-01-27 WO disclosed